shutterstock_2183917051_t-schneider
T. Schneider / Shutterstock.com
3 November 2022Sarah Speight

Analysis: Ventria on ITC win barring rHSA products

Last month, October 2022, the US International Trade Commission ( ITC) affirmed an administrative law judge’s (ALJ’s) finding that products containing recombinant human serum albumins (rHSAs) made by a Chinese company infringe a patent belonging to  Ventria Bioscience.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
29 May 2026   A US appeals court has thrown out a jury verdict against a South Korean medical device company, ruling that Insulet waited too long to bring its trade secret misappropriation claim.
Careers
28 May 2026   The Chicago firm has added a partner with experience across patent litigation and strategic counselling for clients in the pharma, biotech, and advanced technology sectors.
Europe
28 May 2026   A European court dismissed a challenge by a German generics manufacturer, confirming the validity of a patent covering a blood cancer combination therapy.